Form 4: Roivant Sciences President Reports Stock Transaction
Insider Transaction (Form 4)
Mayukh Sukhatme, President & CIO and a Director of Roivant Sciences Ltd., reported a transaction in 46,879 shares of common stock on September 30, 2026.
Summary
- Tax/exercise-price withholding: disposed of 46,879 Common Shares at $36.57 ($1,714,365) on September 30, 2026; holds 18,583,860 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mayukh Sukhatme — Director, Officer (President & CIO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Tax/exercise-price withholding | Common Shares | 46,879 | $37 | $1.7M | 18,583,860 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Tax/exercise-price withholding (46,879 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., neutral, Mayukh Sukhatme
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.